|
1
|
Alphabet Inc. | |||||||
|---|---|---|---|---|---|---|---|---|
|
2
|
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
|
3
|
(In millions) | |||||||
|
4
|
||||||||
|
5
|
Three Months Ended | Nine Months Ended | ||||||
|
6
|
September 30, | September 30, | ||||||
|
7
|
2014 | 2015 | 2014 | 2015 | ||||
|
8
|
(unaudited) | |||||||
|
9
|
||||||||
|
10
|
Operating activities | |||||||
|
11
|
Net income | $2,739 | $3,979 | $9,461 | $11,425 | |||
|
12
|
||||||||
|
13
|
Adjustments | |||||||
|
14
|
Depreciation expense and impairment of property and equipment | 884 | 1,030 | 2,513 | 2,979 | |||
|
15
|
Amortization and impairment of intangible assets | 663 | 218 | 1,199 | 680 | |||
|
16
|
Stock-based compensation expense | 1,290 | 1,432 | 3,092 | 3,767 | |||
|
17
|
Excess tax benefits from stock-based award activities | (175) | (138) | (467) | (354) | |||
|
18
|
Deferred income taxes | (360) | (416) | (498) | (566) | |||
|
19
|
Gain on equity interest | 0 | 0 | (126) | 0 | |||
|
20
|
(Gain) loss on marketable and non-marketable investments, net | (12) | (1) | (251) | 32 | |||
|
21
|
Other | 66 | 41 | 157 | 157 | |||
|
22
|
||||||||
|
23
|
||||||||
|
24
|
Changes in assets and liabilities, net of effects of acquisitions | |||||||
|
25
|
Accounts receivable | (36) | (267) | (490) | (336) | |||
|
26
|
Income taxes, net | 487 | (857) | 577 | 1,093 | |||
|
27
|
Prepaid revenue share, expenses and other assets | (13) | 142 | 506 | 204 | |||
|
28
|
Accounts payable | (127) | 230 | (113) | (168) | |||
|
29
|
Accrued expenses and other liabilities | 484 | 583 | 416 | 820 | |||
|
30
|
Accrued revenue share | 104 | 52 | 36 | (69) | |||
|
31
|
Deferred revenue | 0 | (21) | 0 | (55) | |||
|
32
|
Net cash provided by operating activities | 5,994 | 6,007 | 16,012 | 19,609 | |||
|
33
|
||||||||
|
34
|
Investing activities | |||||||
|
35
|
Purchases of property and equipment | (2,417) | (2,373) | (7,408) | (7,815) | |||
|
36
|
Purchases of marketable securities | (18,335) | (23,091) | (43,192) | (56,217) | |||
|
37
|
Maturities and sales of marketable securities | 13,045 | 19,274 | 36,650 | 46,860 | |||
|
38
|
Purchases of non-marketable investments | (69) | (322) | (536) | (1,771) | |||
|
39
|
Cash collateral related to securities lending | 316 | 572 | 2,029 | 488 | |||
|
40
|
Investments in reverse repurchase agreements | (725) | 225 | (725) | 475 | |||
|
41
|
Acquisitions, net of cash acquired, and purchases of intangibles and other assets | (1,142) | (102) | (4,632) | (244) | |||
|
42
|
Net cash used in investing activities | (9,327) | (5,817) | (17,814) | (18,224) | |||
|
43
|
||||||||
|
44
|
||||||||
|
45
|
Financing activities | |||||||
|
46
|
Net payments related to stock-based award activities | (627) | (606) | (1,548) | (1,610) | |||
|
47
|
Excess tax benefits from stock-based award activities | 175 | 138 | 467 | 354 | |||
|
48
|
Adjustment Payment to Class C capital stockholders | 0 | 0 | 0 | (47) | |||
|
49
|
Proceeds from issuance of debt, net of costs | 2,874 | 3,634 | 9,167 | 10,332 | |||
|
50
|
Repayments of debt | (2,877) | (3,637) | (9,181) | (10,341) | |||
|
51
|
Net cash used in financing activities | (455) | (471) | (1,095) | (1,312) | |||
|
52
|
Effect of exchange rate changes on cash and cash equivalents | (227) | (104) | (236) | (352) | |||
|
53
|
Net decrease in cash and cash equivalents | (4,015) | (385) | (3,133) | (279) | |||
|
54
|
Cash and cash equivalents at beginning of period | 19,620 | 18,453 | 18,898 | 18,347 | |||
|
55
|
Reclassification of assets previously held for sale | 0 | 0 | (160) | 0 | |||
|
56
|
Cash and cash equivalents at end of period | $15,605 | $18,068 | $15,605 | $18,068 | |||